These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31907628)

  • 21. Shipping-Induced Aggregation in Therapeutic Antibodies: Utilization of a Scale-Down Model to Assess Degradation in Monoclonal Antibodies.
    Fleischman ML; Chung J; Paul EP; Lewus RA
    J Pharm Sci; 2017 Apr; 106(4):994-1000. PubMed ID: 27964939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixing monoclonal antibody formulations using bottom-mounted mixers: impact of mechanism and design on drug product quality.
    Gikanga B; Chen Y; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(2):284-96. PubMed ID: 25868994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of PEG-induced precipitation with protein-protein interactions and aggregation rates of high concentration mAb formulations at 5 °C.
    Wälchli R; Fanizzi F; Massant J; Arosio P
    Eur J Pharm Biopharm; 2020 Jun; 151():53-60. PubMed ID: 32197816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do not drop: mechanical shock in vials causes cavitation, protein aggregation, and particle formation.
    Randolph TW; Schiltz E; Sederstrom D; Steinmann D; Mozziconacci O; Schöneich C; Freund E; Ricci MS; Carpenter JF; Lengsfeld CS
    J Pharm Sci; 2015 Feb; 104(2):602-11. PubMed ID: 25418950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody.
    Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB
    J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic Effect of Cavitation and Agitation on Protein Aggregation.
    Torisu T; Maruno T; Hamaji Y; Ohkubo T; Uchiyama S
    J Pharm Sci; 2017 Feb; 106(2):521-529. PubMed ID: 27887723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of Protein-PDMS Visible Particles Formation in Liquid Vial Monoclonal Antibody Formulation.
    Soeda K; Arai K; Yamamoto T; Ofuji K; Fukuda M; Hashimoto D; Yamanaka Y
    J Pharm Sci; 2023 Mar; 112(3):653-664. PubMed ID: 36191621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physicochemical Stability of Monoclonal Antibodies: A Review.
    Le Basle Y; Chennell P; Tokhadze N; Astier A; Sautou V
    J Pharm Sci; 2020 Jan; 109(1):169-190. PubMed ID: 31465737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevant shaking stress conditions for antibody preformulation development.
    Eppler A; Weigandt M; Hanefeld A; Bunjes H
    Eur J Pharm Biopharm; 2010 Feb; 74(2):139-47. PubMed ID: 19922795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Container Surface Passivation on Aggregation of Intravenous Immunoglobulin Induced by Mechanical Shock.
    Movafaghi S; Wu H; Francino Urdániz IM; Bull DS; Kelly MD; Randolph TW; Goodwin AP
    Biotechnol J; 2020 Sep; 15(9):e2000096. PubMed ID: 32437086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation and manufacturability of biologics.
    Shire SJ
    Curr Opin Biotechnol; 2009 Dec; 20(6):708-14. PubMed ID: 19880308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated Aggregation Studies of Monoclonal Antibodies: Considerations for Storage Stability.
    Wälchli R; Vermeire PJ; Massant J; Arosio P
    J Pharm Sci; 2020 Jan; 109(1):595-602. PubMed ID: 31676272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of monoclonal antibody variants involved in aggregate formation - Part 2: Hydrophobicity variants.
    Meyer RM; Berger L; Nerkamp J; Scheler S; Nehring S; Friess W
    Eur J Pharm Biopharm; 2021 Mar; 160():134-142. PubMed ID: 33524536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of Inadequate Temperature Storage Conditions on Aggregate and Particle Formation in Drugs Containing Tumor Necrosis Factor-Alpha Inhibitors.
    Vlieland ND; Nejadnik MR; Gardarsdottir H; Romeijn S; Sediq AS; Bouvy ML; Egberts ACG; van den Bemt BJF; Jiskoot W
    Pharm Res; 2018 Feb; 35(2):42. PubMed ID: 29404710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of surfaces and leachables on the stability of biopharmaceuticals.
    Bee JS; Randolph TW; Carpenter JF; Bishop SM; Dimitrova MN
    J Pharm Sci; 2011 Oct; 100(10):4158-70. PubMed ID: 21523787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration.
    Zidar M; Šušterič A; Ravnik M; Kuzman D
    Pharm Res; 2017 Sep; 34(9):1831-1839. PubMed ID: 28593474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphology and kinetics of asphalt binder microstructure at gas, liquid and solid interfaces.
    Ramm A; Downer MC; Sakib N; Bhasin A
    J Microsc; 2019 Dec; 276(3):109-117. PubMed ID: 31696508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Leachable Study of Glass Vials to Demonstrate the Impact of Low Fill Volume.
    Hladik B; Buscke F; Frost R; Rothhaar U
    PDA J Pharm Sci Technol; 2019; 73(4):345-355. PubMed ID: 30770482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stress.
    Telikepalli S; Kumru OS; Kim JH; Joshi SB; O'Berry KB; Blake-Haskins AW; Perkins MD; Middaugh CR; Volkin DB
    J Pharm Sci; 2015 Feb; 104(2):495-507. PubMed ID: 25522000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.